Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Foucher, J.; Chanteloup, E.; Vergniol, J.; Castéra, L.; Le Bail, B.; Adhoute, X.; Bertet, J.; Couzigou, P.; de Lédinghen, V.
March 2006
Gut;Mar2006, Vol. 55 Issue 3, p403
Academic Journal
Background: Transient elastography (FibroScan) is a new, non-invasive, rapid, and reproducible method allowing evaluation of liver fibrosis by measurement of liver stiffness. In cirrhotic patients, liver stiffness measurements range from 12.5 to 75.5 kPa. However, the clinical relevance of these values is unknown. The aim of this prospective study was to evaluate the accuracy of liver stiffness measurement for the detection of cirrhosis in patients with chronic liver disease. Methods: A total of 711 patients with chronic liver disease were studied. Aetiologies of chronic liver diseases were hepatitis C virus or hepatitis B virus infection, alcohol, non-alcoholic steatohepatitis, other, or a combination of the above aetiologies. Liver fibrosis was evaluated according to the METAVIR scare. Results: Stiffness was significantly correlated with fibrosis stage (r = 0.73, p<0.0001). Areas under the receiver operating characteristic curve (95% confidence interval) were 0.80 (0.75–0.84) for patients with significant fibrosis (F>2), 0.90 (0.86–0.93) for patients with severe fibrosis (F3), and 0.96 (0.94–0.98) for patients with cirrhosis. Using a cut off value of 17.6 kPa, patients with cirrhosis were detected with a positive predictive value and a negative predictive value (NPV) of 90%. Liver stiffness was significantly correlated with clinical, biological, and morphological parameters of liver disease. With an NPV >90%, the cut off values for the presence of oesophageal varices stage 2/3, cirrhosis Child-Pugh B or C, past history of ascites, hepatocellular carcinoma, and oesophageal bleeding were 27.5, 37.5, 49.1, 53.7, and 62.7 kPa, respectively. Conclusion: Transient elastography is a promising non-invasive method for detection of cirrhosis in patients with chronic liver disease. Its use for the follow up and management of these patients could be of great interest and should be evaluated further.


Related Articles

  • Diagnostic Laparoscopy: A Prospective Review of 100 Cases. Herrera, Jorge L.; Brewer, Thomas G.; Peura, David A. // American Journal of Gastroenterology;Sep1989, Vol. 84 Issue 9, p1051 

    The perceived role of laparoscopy in the management of liver disease has changed because of the widespread use of image-guided biopsy. Laparoscopy, however, permits direct inspection of the liver surface and the abdominal cavity, as well as tissue sampling. In order to assess the utility of...

  • Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest–Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study. Halfon, Philippe; Bourliere, Marc; Deydier, Romaric; Botta-Fridlund, Danielle; Renou, Christophe; Tran, Albert; Portal, Isabelle; Allemand, Isabelle; Bertrand, Jean Jacques; Rosenthal-Allieri, Alessandra; Rotily, Michel; Sattonet, Christophe; Benderitter, Thierry; Paul, Marie Christine Saint; Bonnot, Henry Pierre; Penaranda, Guillaume; Degott, Claude; Masseyeff, Marie France; Ouzan, Denis // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p547 

    OBJECTIVES: Fibrotest (FT) and Actitest (AT) are biochemical markers of fibrosis and activity for use as a non-invasive alternative to liver biopsy in patients with chronic hepatitis C virus (HCV). The aim of this study was to perform an external validation of FT and AT and to study the...

  • Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B. Beom Kyung Kim; Seung Up Kim; Hyon Suk Kim; Jun Yong Park; Sang Hoon Ahn; Chae Yoon Chon; In Rae Cho; Dong-Hoo Joh; Young Nyun Park; Kwang-Hyub Han; Do Young Kim // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background and Aims: Diagnostic values of FibroTest (FT) for hepatic fibrosis have rarely been assessed in Asian chronic hepatitis B (CHB) patients. We aimed to validate its diagnostic performances in comparison with liver stiffness (LS). Methods: From 2008 to 2010, 194 CHB patients who...

  • Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies. Nseir, William; Mograbi, Julnar; Ghali, Murad // Digestive Diseases & Sciences;Jul2012, Vol. 57 Issue 7, p1773 

    Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which refers to the presence of hepatic steatosis without significant intake of alcohol. NAFLD is an asymptomatic disease that can progress to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular...

  • Survey of 2002 cases of liver cirrhosis : Identification of etiological factors and related complications. AL, Min; CHEN, Weichan; SHEN, Wei // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;May2013, Vol. 29 Issue 5, p352 

    To identify the etiologies and associated complications of liver cirrhosis for new cases emerging over the past decade in the region served by the Second Affiliated Clinical College of Chongqing University of Medical Sciences. Methods The institute's inpa-tient medical record database was...

  • Performance of a New Elastographic Method (ARFI technology) Compared to Unidimensional Transient Elastography in the Noninvasive Assessment of Chronic Hepatitis C. Preliminary Results. Lupsor, Monica; Badea, Radu; Stefanescu, Horia; Sparchez, Zeno; Branda, Horaţiu; Serban, Alexandru; Maniu, Anca // Journal of Gastrointestinal & Liver Diseases;Sep2009, Vol. 18 Issue 3, p303 

    Background and aims: The current study aims to evaluate the performance of a new elastographic method (ARFI) in noninvasive fibrosis assessment and to compare it to another validated technology (transient elastography, TE). Method: 112 consecutive chronic hepatitis C patients (histologically...

  • Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B. Lebensztejn, D. M.; Skiba, E.; Werpachowska, I.; Sobaniec-Łotowska, M. E.; Kaczmarski, M. // Advances in Medical Sciences (De Gruyter Open);2007, Vol. 52, p120 

    Purpose: The aim of the study was to evaluate the serum concentration of YKL-40 (human cartilage glycoprotein-39) in the assessment of fibrosis stage in children compared to biopsy and prior to antiviral treatment for chronic hepatitis B. Material and methods: We determined serum level of YKL-40...

  • Occult HBV infection among Egyptian hepatocellular carcinoma patients. Hassan, Zeinab K.; Hafez, Mohamed M.; Mansor, Tarek M.; Zekri, Abdel Rahman N. // Virology Journal;2011, Vol. 8 Issue 1, p90 

    Background: Occult HBV infection accelerates the progression of liver fibrosis, cirrhosis, and finally leading to hepatocellular carcinoma (HCC). This study analyzed the occult HBV-genotypes in HCC patients. Methods: To achieve our objective, matched serum and tissue samples were collected from...

  • Chronic hepatitis and cirrhosis. Neuberger, James; Keogh, Belinda // GP: General Practitioner;4/6/2007, p42 

    The article presents information on chronic hepatitis and cirrhosis. Chronic hepatitis implies inflammation in the liver persisting for three months or more. Cirrhosis is a pathological term that reflects the combination of nodule formation, fibrosis and regeneration. Great Britain and Scotland...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics